[1]Amjadi F, Aflatoonian R, Javanmard SH, et al. Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: a case-control study[J]. J Res Med Sci, 2015, 20:1039-1045. [2]于彩虹,刘梅梅,李肖肖,等.多囊卵巢综合征(PCOS)患者子宫内膜容受性的研究进展[J].中国优生与遗传杂志,2016,24:131-133. [3]管海云,张炜.多囊卵巢综合征对子宫内膜容受性的影响[J].生殖医学杂志,2016,25:1122-1125. [4]李予,苏圣梅,杨冬梓.多囊卵巢综合征患者子宫内膜容受性的特点[J].生殖与避孕,2014,34:571-575. [5]Singh M,Chaudhry P,Asselin E.Bridging endometrial receptivity and implantation:network of hormones,cytokines,and growth factors[J].J Endocrinol,2011,21:5-14. [6]文隽,胡兵,赵云.不孕症患者子宫内膜容受性的评估及改善研究[J].中华生殖与避孕杂志,2017,37:602-605. [7]王会妍,张帅,张云山.胚胎移植前宫腔内灌注hCG在IVF-ET中的应用及hCG提高种植率和妊娠率的有关机制[J].生殖与避孕,2012,32:593-598. [8]Licht P.Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis[J].Hum Reprod Update,1998,4:532-538. [9]Mansour R,Tawab N,Kamal O,et al.Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection:aprospective randomized study[J].Fertil Steril,2011,96:1370-1374. [10]王巧凤,杨帆.雌、孕激素受体、生长激素受体、胰岛素样生长因子1受体与子宫内膜容受性的关系[J].中华生殖与避孕杂志,2017,37:855-859. [11]徐丽珍.促排卵过程中卵巢高反应对子宫内膜容受性的影响及其相关机制[D].济南:山东大学,2017,27-30. [12]杨雪峰,刘丽伟,李爱杰.C-FOS、STAT3在PCOS患者着床窗口期子宫内膜的表达及意义[J].当代医学,2016,22:1-2. |